Clinical Trial Update: Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety and imaging effects of porphysome nanoparticles in gynecologic cancers and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• Porphysome nanoparticles

Snippet

Sponsor: University Health Network, Toronto | Conditions: Gynecological Cancers | Phase 1 | Status: RECRUITING